Clinical trial
Autologous Peripheral Stem Cell Transplant in Treating Patients With…
NCT00345865 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00345865 |
|---|---|
| Title | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma |
| Official title | Autologous Peripheral Blood Stem Cell Transplant for Patients With Lymphoma |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | carmustine, cyclophosphamide, etoposide, peripheral blood stem cell transplantation, irradiation therapy, G-CSF, Cytarabine |
| Enrollment | 473 |
| Start date | Aug 24, 2005 |
| Primary completion | Jun 28, 2019 |
| Completion | Jun 28, 2019 |
| First posted | Jun 29, 2006 |
| Last update posted | Jul 14, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: